H-1B sponsorship profile: Longboard Pharmaceuticals, Inc. Across U.S. Department of Labor LCA disclosures, Longboard Pharmaceuticals, Inc filed 3 Labor Condition Applications covering 3 H-1B worker positions between fiscal year 2024 and fiscal year 2025. The employer’s DOL certification rate sits at 100% (3 certified of 3 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Longboard Pharmaceuticals, Inc’s H-1B petitions range from $157,435 at the low end to $207,979 at the high end, with a petition-weighted average of $176,696. That range reflects the mix of occupations the company sponsors, led by Sr. Manager/Associate Director, Drug Safety Operations (1 petitions at $157,435 avg), followed by Senior Global Clinical Trial Lead and Director, Drug Safety Operations. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Longboard Pharmaceuticals, Inc is headquartered in La Jolla, CA under NAICS code 32541, and places H-1B workers across 2 states, most heavily in CA, NY. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where Longboard Pharmaceuticals, Inc ranks. By H-1B petition volume, Longboard Pharmaceuticals, Inc is #37,433 of 119,880 employers nationally and #6,671 of 22,893 employers headquartered in CA. Both ranks are computed live from the same underlying petition counts, not a separate estimate.